Semaglutide Use and Risks

The recent entry of generic semaglutide brands into the Indian market has raised concerns about its misuse. After the patent expiry of the innovator company Novo Nordisk, cheaper versions of this anti-obesity and anti-diabetic drug are now widely available. Experts warn that unsupervised use, especially for cosmetic weight loss, poses health risks. Semaglutide requires prescription, clinical monitoring, and lifestyle changes to be safe and effective.

Semaglutide – Medical Use and Mechanism

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It helps control blood sugar in type 2 diabetes and promotes weight loss in obesity. The drug works by reducing appetite and slowing gastric emptying. Its use is intended for carefully selected patients under medical supervision with dose adjustments over time.

Concerns Over Misuse and Accessibility

With generic versions available, semaglutide is increasingly sold through online pharmacies and wellness clinics, often without prescriptions. This leads to misuse for cosmetic purposes rather than medical need. Unsupervised consumption can cause serious side effects like pancreatitis, kidney injury, dehydration, and vision problems. It is not a substitute for diet and exercise.

Long-Term Safety and Regulatory Measures

Long-term use of semaglutide can cause gastrointestinal complications, gallbladder disease, and possible eye disorders such as diabetic retinopathy and ischemic optic neuropathy. Regulatory bodies must enforce prescription rules, audit online sales, and curb misleading advertisements. Pharmacovigilance and public awareness are crucial to ensure patient safety.

Role of Lifestyle and Monitoring

Semaglutide’s benefits depend heavily on concurrent lifestyle changes including diet and physical activity. Rapid weight loss without medical oversight can lead to muscle loss, nutritional deficiencies, and cardiovascular stress. Continuous monitoring by healthcare professionals is essential to manage dose and side effects.

Topics for Prelims:

Semaglutide

1. GLP-1 receptor agonist used for diabetes and obesity.
2. Reduces appetite and slows gastric emptying.
3. Requires prescription and medical supervision.
4. Risks include pancreatitis, kidney injury, and vision problems.
5. Not a replacement for lifestyle changes.

Patent Expiry and Generics

1. Patent expiry allows generic drug entry.
2. Generics reduce cost and increase accessibility.
3. Risk of misuse rises without prescription enforcement.
4. Online pharmacies facilitate unsupervised sales.
5. Regulatory oversight needed for safe use.

Regulatory and Safety Concerns

1. Schedule H prescription norms apply to semaglutide.
2. Need for digital prescription validation systems.
3. Periodic audits of pharmacies and clinics.
4. Pharmacovigilance to monitor adverse effects.
5. Public education on drug risks is essential.

Questions for Mains:

1. Critically analyse the impact of patent expiry on drug accessibility and misuse in India with suitable examples. [GS-III-Economic Development]
2. Comment on the role of regulatory frameworks in controlling the misuse of prescription drugs in the digital age, citing semaglutide as a case study. [GS-II-Governance]
3. What are the challenges in balancing the benefits and risks of new pharmaceutical drugs in public health policy? Explain with reference to obesity management. [GS-II-Constitution of India & Polity]
4. Underline the importance of lifestyle interventions in managing obesity and diabetes and discuss the limitations of pharmacological treatments like semaglutide. [GS-III-Science & Technology]

Answer Hints:

1. Critically analyse the impact of patent expiry on drug accessibility and misuse in India with suitable examples. [GS-III-Economic Development]

1. Patent expiry enables entry of generic drugs, reducing prices and improving affordability.
2. Example – Semaglutide generics flooding Indian market post Novo Nordisk patent expiry.
3. Increased accessibility can lead to wider therapeutic use but also potential misuse.
4. Misuse arises from easier availability without prescription, especially via online pharmacies and wellness clinics.
5. Cost reduction incentivizes over-the-counter sales, risking unsupervised consumption and health hazards.
6. Need for balanced policy to enhance access while preventing irrational use and protecting public health.

2. Comment on the role of regulatory frameworks in controlling the misuse of prescription drugs in the digital age, citing semaglutide as a case study. [GS-II-Governance]

1. Strict enforcement of Schedule H drug prescription norms essential to control misuse.
2. Digital prescription validation and monitoring systems to verify legitimacy of drug sales online.
3. Periodic audits and accountability of pharmacists and wellness clinics to curb unauthorized dispensing.
4. Regulation of misleading advertisements to prevent false claims and self-medication trends.
5. Pharmacovigilance systems to track adverse drug reactions and inform policy adjustments.
6. Public awareness campaigns to educate on risks of unsupervised drug use, as seen with semaglutide.

3. What are the challenges in balancing the benefits and risks of new pharmaceutical drugs in public health policy? Explain with reference to obesity management. [GS-II-Constitution of India & Polity]

1. Ensuring equitable access while preventing misuse and adverse effects is a key policy challenge.
2. Drugs like semaglutide are effective but require medical supervision, dose titration, and lifestyle support.
3. Rapid commercialization and availability can lead to unsupervised use and health complications.
4. Monitoring long-term safety is difficult due to evolving evidence and diverse patient profiles.
5. Need for integrated approach combining regulation, clinical guidelines, and public education.
6. Balancing innovation incentives for pharma companies with public health priorities and affordability.

4. Underline the importance of lifestyle interventions in managing obesity and diabetes and discuss the limitations of pharmacological treatments like semaglutide. [GS-III-Science & Technology]

1. Lifestyle changes (diet, exercise) are foundational for sustainable obesity and diabetes management.
2. Pharmacological agents like semaglutide aid weight loss by appetite suppression and delayed gastric emptying.
3. Semaglutide is not a substitute for lifestyle modifications; benefits are limited and often temporary without them.
4. Rapid weight loss from drugs alone risks muscle loss, nutritional deficiencies, and cardiovascular stress.
5. Unsupervised drug use can cause serious side effects – pancreatitis, kidney injury, vision problems.
6. Continuous medical monitoring and patient education vital to maximize benefits and minimize risks.